# Can 5-Amino-1MQ inhibit alcohol-related fatty liver development?

Canonical source: https://retacompare.com/research/can-5-amino-1mq-inhibit-alcohol-related-fatty-liver-development

Peptide Longevity Q&A · 2020-10-01


    Research indicates that 5-Amino-1MQ, through NNMT inhibition, may prevent fatty liver development associated with chronic alcohol consumption. This inhibition is linked to reduced de novo lipogenesis and enhanced AMPK activation, suggesting a potential therapeutic role in alcohol-related liver disease.

 What the research shows

The study published in the Journal of Hepatology investigates the role of N-nicotinamide methyltransferase (NNMT) in the development of alcohol-related fatty liver disease (ALD). Using both traditional Lieber-De Carli and NIAAA mouse models of ALD, researchers assessed the impact of chronic alcohol consumption on NNMT expression in the liver. They discovered that alcohol induces endoplasmic reticulum (ER) stress, which subsequently upregulates NNMT expression. The study utilized genetic and pharmacological approaches to inhibit NNMT, revealing that both methods effectively prevented fatty liver development in response to chronic alcohol feeding. This was associated with downregulation of genes involved in de novo lipogenesis, such as Srebf1, Acaca, Acacb, and Fasn. Notably, NNMT inhibition also led to increased cellular NAD+, which was linked to enhanced liver AMPK activation.

 Why it matters for longevity

The findings from this research are significant in the context of longevity and metabolic health. Alcohol-related liver disease is a growing concern, particularly as it can lead to more severe liver conditions and impact overall healthspan. By targeting NNMT with 5-Amino-1MQ, there is potential to mitigate the adverse effects of chronic alcohol consumption on liver health. The study suggests that inhibiting NNMT may not only reduce fatty liver development but also enhance metabolic regulation through AMPK activation. This could have broader implications for aging, as metabolic dysregulation is a hallmark of age-related diseases. Therefore, understanding the role of NNMT and the effects of 5-Amino-1MQ could contribute to developing strategies for promoting healthier aging.

 Key findings at a glance

Chronic alcohol consumption induces ER stress and upregulates NNMT in the liver.

NNMT inhibition prevents fatty liver development in alcohol-fed models.

Downregulation of lipogenic genes occurs with NNMT inhibition.

Increased cellular NAD+ and AMPK activation are associated with NNMT inhibition.

ER stress via the PERK-ATF4 pathway is crucial for NNMT upregulation.

 How 5-Amino-1MQ works (background)

5-Amino-1MQ functions as an inhibitor of NNMT, an enzyme that catalyzes the degradation of nicotinamide. Elevated NNMT levels in the liver have been linked to metabolic dysregulation, particularly in the context of alcohol consumption. The study highlights that chronic alcohol exposure activates the PERK-ATF4 pathway, leading to increased NNMT expression. By inhibiting NNMT, 5-Amino-1MQ can reduce the lipogenic activity associated with fatty liver development while promoting AMPK activation, which plays a role in energy homeostasis. This mechanism underscores the potential of 5-Amino-1MQ in addressing metabolic disorders related to alcohol consumption.

 Safety, caveats, and what we don't yet know

While the research indicates promising results regarding NNMT inhibition and fatty liver prevention, it is essential to note that these findings are based on preclinical models. The long-term safety and efficacy of 5-Amino-1MQ in humans have not yet been established. Further studies are needed to evaluate its effects across diverse populations and to understand potential side effects. Additionally, the specific mechanisms by which NNMT inhibition influences broader metabolic pathways require further investigation to clarify the implications for longevity and overall health.

 Bottom line

The research suggests that 5-Amino-1MQ may inhibit alcohol-related fatty liver development through NNMT inhibition, which is associated with reduced lipogenesis and enhanced AMPK activation.

 Related questions

 How does 5-Amino-1MQ affect metabolic health?

5-Amino-1MQ may improve metabolic health by inhibiting NNMT, which is linked to reduced fatty liver and enhanced energy regulation through AMPK activation.

 What role does NNMT play in liver disease?

NNMT is implicated in the pathogenesis of alcohol-related liver disease, as its overexpression is associated with increased lipogenic activity and fatty liver development.

 Can 5-Amino-1MQ be combined with other therapies?

While research is ongoing, combining 5-Amino-1MQ with other metabolic interventions may enhance therapeutic outcomes in liver disease and metabolic disorders.

 Source: PubMed · J Hepatol · published 2020-10-01.

## Sources

- PubMed · J Hepatol: https://pubmed.ncbi.nlm.nih.gov/32389809/